Retatrutide, also known as LY-3437943 or “triple G” is an investigational multi-agonist peptide studied for its activity at GLP-1, GIP and glucagon receptors. Early research indicates potential effects on appetite regulation and metabolic pathways, making it a notable compound in obesity-related studies.
Product Features:
• Lyophilised research peptide – requires bacteriostatic water for reconstitution (sold separately)
• Supplied in sterile 3ml vials
• Designed for laboratory and in vitro research only
Research Handling & Storage:
• Once reconstituted: Stable for up to 8 weeks when stored at 2–8°C (refrigerated)
• Protect from light and moisture
Disclaimer:
For research use only. Not for human consumption or clinical use.
Product images are for illustrative purposes only. Packaging details, including vial cap colour, may vary between production batches. Product quality and specifications remain unchanged.
Retatrutide, also known as LY-3437943 or “triple G” is an investigational multi-agonist peptide studied for its activity at GLP-1, GIP and glucagon receptors. Early research indicates potential effects on appetite regulation and metabolic pathways, making it a notable compound in obesity-related studies.
Product Features:
• Lyophilised research peptide – requires bacteriostatic water for reconstitution (sold separately)
• Supplied in sterile 3ml vials
• Designed for laboratory and in vitro research only
Research Handling & Storage:
• Once reconstituted: Stable for up to 8 weeks when stored at 2–8°C (refrigerated)
• Protect from light and moisture
Disclaimer:
For research use only. Not for human consumption or clinical use.
Product images are for illustrative purposes only. Packaging details, including vial cap colour, may vary between production batches. Product quality and specifications remain unchanged.
